Jump to main content
Key references: Drug therapy for postpartum lactation suppression
Bromocriptine. In LactMed: NCBI Bookshelf. Bethesda, Md: US National Library of Medicine; 2020. https://www.ncbi.nlm.nih.gov/books/NBK501306/
Cabergoline. In LactMed: NCBI Bookshelf. Bethesda, Md: US National Library of Medicine; 2020. https://www.ncbi.nlm.nih.gov/books/NBK501327/
Bernard N, Jantzem H, Becker M, Pecriaux C, Benard-Laribiere A, Montastruc JL, et al. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey. BJOG 2015;122(9):1244–51. https://www.ncbi.nlm.nih.gov/pubmed/25761676
King Edward Memorial Hospital Obstetrics and Midwifery. Clinical practice guideline. Breastfeeding: suppression of lactation. Perth: Government of Western Australia; 2017. https://www.kemh.health.wa.gov.au/For-health-professionals/Clinical-guidelines/OG
Palasanthiran P, Starr M, Jones C, Giles M, eds. Management of perinatal infections. Sydney: Australasian Society for Infectious Diseases (ASID); 2014. https://www.asid.net.au/resources/clinical-guidelines
The Royal Hospital for Women. Local operating procedure. Suppressing lactation and weaning. South East Sydney: NSW Government; 2016. https://www.seslhd.health.nsw.gov.au/royal-hospital-for-women/policies-and-publications/a-z/s